Migraine

(Image: Getty/Klebercordeiro)

Lilly expands migraine offerings after FDA approval

By Ben Hargreaves

US FDA gives marketing authorization to Lilly’s oral medication for the acute treatment of migraines in adult patients, adding to its Emgality approval almost exactly a year ago.

Endo acquires migraine treatment, needle-free delivery system for $85M

Endo acquires migraine treatment, needle-free delivery system for $85M

By Zachary Brennan

Endo Pharmaceuticals, which previously lost a bid to acquire a migraine treatment, has now acquired worldwide rights to Sumavel DosePro (sumatriptan injection) for subcutaneous use, which is a needle-free delivery system for Zogenix’s migraine treatment...